OPKO Health (OPK) Competitors $1.54 -0.03 (-1.91%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends OPK vs. FOLD, LGND, GERN, CLDX, MNKD, DVAX, BCRX, NVAX, MYGN, and INVAShould you be buying OPKO Health stock or one of its competitors? The main competitors of OPKO Health include Amicus Therapeutics (FOLD), Ligand Pharmaceuticals (LGND), Geron (GERN), Celldex Therapeutics (CLDX), MannKind (MNKD), Dynavax Technologies (DVAX), BioCryst Pharmaceuticals (BCRX), Novavax (NVAX), Myriad Genetics (MYGN), and Innoviva (INVA). These companies are all part of the "biotechnology" industry. OPKO Health vs. Amicus Therapeutics Ligand Pharmaceuticals Geron Celldex Therapeutics MannKind Dynavax Technologies BioCryst Pharmaceuticals Novavax Myriad Genetics Innoviva Amicus Therapeutics (NASDAQ:FOLD) and OPKO Health (NASDAQ:OPK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Do analysts rate FOLD or OPK? Amicus Therapeutics presently has a consensus target price of $16.88, indicating a potential upside of 72.19%. OPKO Health has a consensus target price of $2.75, indicating a potential upside of 78.57%. Given OPKO Health's stronger consensus rating and higher probable upside, analysts clearly believe OPKO Health is more favorable than Amicus Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amicus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78OPKO Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, FOLD or OPK? Amicus Therapeutics has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Which has stronger valuation and earnings, FOLD or OPK? Amicus Therapeutics has higher earnings, but lower revenue than OPKO Health. Amicus Therapeutics is trading at a lower price-to-earnings ratio than OPKO Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmicus Therapeutics$493.67M5.93-$151.58M-$0.34-28.82OPKO Health$711.41M1.48-$188.86M-$0.19-8.11 Does the MarketBeat Community favor FOLD or OPK? Amicus Therapeutics received 24 more outperform votes than OPKO Health when rated by MarketBeat users. Likewise, 73.17% of users gave Amicus Therapeutics an outperform vote while only 65.76% of users gave OPKO Health an outperform vote. CompanyUnderperformOutperformAmicus TherapeuticsOutperform Votes52973.17% Underperform Votes19426.83% OPKO HealthOutperform Votes50565.76% Underperform Votes26334.24% Is FOLD or OPK more profitable? OPKO Health has a net margin of -18.65% compared to Amicus Therapeutics' net margin of -21.21%. OPKO Health's return on equity of -9.76% beat Amicus Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Amicus Therapeutics-21.21% -15.97% -3.17% OPKO Health -18.65%-9.76%-6.46% Do institutionals & insiders have more ownership in FOLD or OPK? 64.6% of OPKO Health shares are owned by institutional investors. 2.2% of Amicus Therapeutics shares are owned by insiders. Comparatively, 47.3% of OPKO Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media favor FOLD or OPK? In the previous week, Amicus Therapeutics had 9 more articles in the media than OPKO Health. MarketBeat recorded 10 mentions for Amicus Therapeutics and 1 mentions for OPKO Health. OPKO Health's average media sentiment score of 0.46 beat Amicus Therapeutics' score of 0.42 indicating that OPKO Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amicus Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral OPKO Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryOPKO Health beats Amicus Therapeutics on 11 of the 18 factors compared between the two stocks. Ad WealthPressYour chance to get on the next “60-Second Trade”Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPK vs. The Competition Export to ExcelMetricOPKO HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05B$6.57B$5.13B$9.08BDividend YieldN/A2.99%4.93%4.22%P/E Ratio-8.1110.5589.6617.18Price / Sales1.48195.351,115.28116.98Price / CashN/A57.1642.8237.86Price / Book0.865.094.794.78Net Income-$188.86M$151.51M$120.04M$225.60M7 Day Performance-3.14%-2.13%-1.91%-1.23%1 Month Performance-1.91%-3.10%11.48%3.36%1 Year Performance-3.75%11.54%30.60%16.60% OPKO Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPKOPKO Health4.1694 of 5 stars$1.54-1.9%$2.75+78.6%-1.3%$1.05B$711.41M-8.113,930Analyst UpgradeFOLDAmicus Therapeutics4.3254 of 5 stars$9.90+5.8%$16.88+70.5%-23.7%$2.96B$493.67M-28.71480Analyst DowngradeLGNDLigand Pharmaceuticals4.983 of 5 stars$123.60+5.7%$147.00+18.9%+65.4%$2.34B$152.42M47.4480Analyst RevisionGERNGeron3.8435 of 5 stars$3.79-1.8%$7.15+88.7%+61.6%$2.29B$29.48M-12.06141Short Interest ↓CLDXCelldex Therapeutics2.6659 of 5 stars$26.43+4.0%$62.25+135.5%-33.5%$1.75B$6.88M-9.89160Analyst ForecastNews CoveragePositive NewsMNKDMannKind3.1849 of 5 stars$6.29-3.8%$8.67+37.8%+105.4%$1.73B$198.96M93.43400Analyst UpgradeAnalyst RevisionNews CoverageDVAXDynavax Technologies4.6668 of 5 stars$12.98+0.2%$22.00+69.5%-4.1%$1.71B$260.81M100.00408News CoveragePositive NewsBCRXBioCryst Pharmaceuticals3.713 of 5 stars$7.36-2.3%$15.60+112.0%+34.2%$1.52B$412.58M-12.34530News CoveragePositive NewsNVAXNovavax3.8425 of 5 stars$9.28+1.9%$17.83+92.2%+77.2%$1.49B$847.25M-4.031,543MYGNMyriad Genetics4.4439 of 5 stars$14.06-2.6%$24.27+72.6%-34.3%$1.28B$823.60M-11.102,700INVAInnoviva2.0044 of 5 stars$18.54-0.2%N/A+11.7%$1.16B$310.46M26.93112 Related Companies and Tools Related Companies FOLD Competitors LGND Competitors GERN Competitors CLDX Competitors MNKD Competitors DVAX Competitors BCRX Competitors NVAX Competitors MYGN Competitors INVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OPK) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
